SCHEMBL27756751

SCHEMBL27756751

CC(C)(C)NC(=O)OCCC(C)(C)Nc1ccc(C(F)(F)F)cc1[N+](=O)[O-]

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
PKM P14618 1/20 0.48
MAPT P10636 8/20 0.47
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MAPK1 P28482 3/20 0.46
LMNA P02545 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
STAT3 P40763 1/20 0.45
GAA P10253 1/20 0.45
THRB P10828 1/20 0.45
KCNMA1 Q12791 1/20 0.44
AKR1B1 P15121 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192206 0.80 KMT2A (0.52) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL27756761 0.79 MAPT (0.47) KMT2AMEN1MAPTALDH1A1SMN1; SMN2
SCHEMBL4393888 0.79 MAPT (0.54) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL4393879 0.79 MAPT (0.54) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL7188544 0.79 MAPK1 (0.55) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL116538 0.77 MAPK1 (0.62) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL27756747 0.77 MAPT (0.47) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL1855648 0.77 MAPT (0.50) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL1855646 0.77 MAPT (0.50) KMT2AMEN1PKMMAPTALDH1A1
SCHEMBL27641472 0.73 MAPT (0.53) KMT2AMEN1PKMMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101400675-A Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments BOEHRINGER INGELHEIM INT (DE) 2009-04-01 CN disclosed